M. Leßmann

Biosynthesis of the endogenous cyclic adenosine monophosphate (AMP) antagonist, prostaglandylinositol cyclic phosphate (cyclic PIP), from prostaglandin E and activated inositol polyphosphate in rat liver plasma membranes

H. K. Wasner, M. Leßmann, M. Conrad, 1996, Acta Diabetologica.

Ketoconazole inhibition of the bifunctional cytochrome P450c17 does not affect androgen formation from the endogenous lyase substrate. The catalytic site remains refractory in the course of intermediary hydroxyprogesterone processing.

M. Leßmann, W. Kühn‐Velten, 1992, Biochemical pharmacology.

Specific accumulation of 17 alpha-hydroxyprogesterone in microsomal membranes during the process of cytochrome P-450(C-17)-catalysed androgen biosynthesis. A dynamic study of intermediate formation and turnover.

M. Leßmann, M. Förster, W. Staib, 1988, The Biochemical journal.

Non-invasive infrared-spectroscopic measurements of intravasal oxygen content in xenotransplanted tumours on nude mice--correlation to growth rate.

C. Streffer, M. Leßmann, F. Steinberg, 1994, Advances in experimental medicine and biology.

Prostaglandyl-Inositol Cyclic-Phosphate, A New Second Messenger

H. K. Wasner, M. Leßmann, R. Kaufmann, 1991 .

Degradation of the Cyclic AMP Antagonist Prostaglandylinositol Cyclic Phosphate (Cyclic PIP) by Dephosphorylation

H. K. Wasner, M. Leßmann, A. Kassner, 1999, Biological chemistry.